Centiva Capital, LP

Source: SEC Form 13F · as of Mar 2026

Centiva Capital, LP holds 72 biotech & pharma companies tracked by BioSniper, totaling $781.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

72

Total value held

$781.1M

CompanySharesValue
PFEPFIZER INC5,106,095$143.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)500,295$135.4M
LLYELI LILLY & Co139,377$128.2M
AMGNAMGEN INC323,583$113.9M
BMYBRISTOL MYERS SQUIBB CO1,266,433$76.8M
UTHRUNITED THERAPEUTICS Corp51,500$30.5M
MRKMerck & Co., Inc.203,008$24.4M
ABVXAbivax SA179,450$20.0M
NVONovo Nordisk A/S526,389$19.3M
TERNTerns Pharmaceuticals, Inc.314,025$16.6M
REGNREGENERON PHARMACEUTICALS, INC.14,610$11.3M
MRNAModerna, Inc.137,533$7.0M
INSMINSMED Inc27,347$4.5M
QGENQIAGEN N.V.100,000$4.0M
CYTKCYTOKINETICS INC58,000$3.8M
TEVATeva Pharmaceutical Industries Limited125,000$3.8M
SLNOSOLENO THERAPEUTICS INC101,234$3.4M
EWTXEdgewise Therapeutics, Inc.83,939$2.6M
MLTXMoonLake Immunotherapeutics115,900$2.2M
DAWNDay One Biopharmaceuticals, Inc.100,000$2.1M
QUREuniQure N.V.120,900$2.0M
GILDGILEAD SCIENCES, INC.12,252$1.7M
RGNXREGENXBIO Inc.200,000$1.7M
VERAVera Therapeutics, Inc.33,790$1.4M
MANEVeradermics Incorporated20,000$1.3M
INBXInhibrx Biosciences, Inc.17,739$1.2M
RZLTRezolute, Inc.387,200$1.2M
DVADaVita Inc.7,559$1.2M
ABSIAbsci Corporation362,700$1.1M
IPEXInflection Point Acquisition Corp. V100,000$1.0M
VRTXVERTEX PHARMACEUTICALS INC / MA2,147$959K
CTMXCytomX Therapeutics, Inc.200,000$940K
ROIVRoivant Sciences Ltd.32,596$903K
VKTXViking Therapeutics, Inc.23,258$757K
RNAAtrium Therapeutics Inc.55,895$747K
RVMDREVOLUTION MEDICINES, INC.7,525$732K
OCULOCULAR THERAPEUTIX, INC85,600$725K
CMPSCOMPASS Pathways plc125,000$691K
PLRXPLIANT THERAPEUTICS, INC.432,525$545K
PMPhilip Morris International Inc2,973$492K
PRAXPraxis Precision Medicines, Inc.1,501$484K
OCSOculis Holding AG18,145$482K
BNTXBioNTech SE5,300$471K
MMSIMerit Medical Systems Inc.5,925$408K
BBNXBeta Bionics Inc.39,157$392K
RYTMRHYTHM PHARMACEUTICALS, INC.4,000$348K
CAHCardinal Health Inc.1,583$335K
INNVINNOVUS PHARMACEUTICALS, INC.40,631$326K
MCKMcKesson Corporation338$292K
CCXIChemoCentryx, Inc.28,300$288K
ANTXAN2 Therapeutics, Inc.75,000$257K
CLOVClover Health Investments Corp.142,122$250K
STIMNeuronetics Inc.169,319$246K
ARRYARRAY BIOPHARMA INC33,432$242K
GMOptec International, Inc.3,186$237K
ELVElevance Health Inc.800$234K
AXSMAxsome Therapeutics, Inc.1,288$218K
PROFProfound Medical Corp.29,280$190K
KPTIKaryopharm Therapeutics Inc.33,810$188K
XNCRXencor Inc12,299$148K
REPLReplimune Group, Inc.18,000$138K
OSCROscar Health Inc.10,000$115K
AARDAardvark Therapeutics, Inc.24,782$93K
KRMDKORU Medical Systems Inc. Common Stock (DE)18,902$82K
LUCDLucid Diagnostics Inc.69,063$79K
ACHAccendra Health Inc.33,450$76K
SOPHSOPHiA GENETICS SA12,549$62K
HELPCYBIN INC.10,000$48K
LFVNLifevantage Corp10,619$46K
TMCITreace Medical Concepts Inc.28,311$38K
BKHARBlack Hawk Acquisition Corp19,445$26K
MREOMereo BioPharma Group plc25,000$8K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Centiva Capital, LP — Biotech 13F Holdings & Portfolio | BioSniper